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ABSTRACT
Background: Tree nut allergy is characterized by a high frequency of life-threatening reactions and is typically
lifelong persistent. Some people with a pistachio nut allergy, which is common in the pistachio rich area of Iran,
develop a hypersensitivity to other tree nuts as well. The aim of this study was to investigate the prevalence of
pistachio nut allergy in Iran, the major pistachio cultivation region in the world. The study also addressed the
presence of allergenic cross-reactivity between pistachio and other nuts, including almond, peanut, and
cashew in pistachio allergic patients.
Methods: A survey was conducted to determine whether the prevalence of pistachio allergy is affected by ex-
posure to this nut in pistachio cultivation regions, as well as possible cross-reactivity between pistachio and
other nuts including cashew, almond, and peanut. Inhibition Western blot and inhibition ELISA studies were
conducted to assess the presence of allergenic cross-reactivity between pistachio and the other tree nuts.
Results: Our results revealed that the prevalence of pistachio allergy is twice as much in pistachio cultivation
regions than other areas. Western blotting and inhibition ELISA presented high percentages of inhibition with
pistachio and cashew, followed by almond and, to some degree, peanut which indicates different levels of aller-
genic cross-reactivity.
Conclusions: The results indicate that exposure of people to pistachio significantly affects the prevalence of
its allergic reactions. In addition, it was observed that, among pistachio allergic subjects, such exposure may
affect the co-sensitivities with other nuts, including cashew and almond. The plant taxonomic classification of
pistachio and other tree nuts does appear to predict allergenic cross-reactivity.
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INTRODUCTION
Tree nut allergies are one of the most common, se-
vere and long lasting food allergies among children
and adults. Recently, in addition to peanut allergy, al-
lergy to other tree nuts, such as cashew, walnuts, al-
mond, pistachio, hazel nuts, and pecans have gained
much attention in the United States and Europe due
to their high risk of inducing severe anaphylactic re-
actions.1 Similar to other tree nuts, pistachio are also
known to be a source of food allergens.2-4 Most iden-
tified tree nut allergens are seed storage proteins
which accumulate during seed development. They
belong to major protein super-families such as vicilins
(7S trimeric globulins composed of ～50 kDa
subunits), legumins (11-13S hexameric globulins
with subunits of 30 to 40 kDa acidic and 17 to 20 kDa
basic peptides), and 2S albumins (～15 kDa) with～9
and ～5 kDa subunits.5 The composition of proteins
isolated from pistachio nut indicates that 66% of total
proteins were globulins while albumins, glutelins,
and prolamins made up 25%, 7%, and 2% of total pro-
teins, respectively.6 Albumins and globulins are the
major seed storage proteins of angiosperms and also
important cross-reactive food allergens.7 So far, the
major allergens of pistachio nut have been identified
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and characterized as Pis v1, a 2S albumin; Pis v 2, a
11S globulin subunit, Pis v 3, a vicillin, Pis v 4, a man-
ganese superoxide dismutase, and Pis v 5, a 11S
globulin subunit.2-4 Among these pistachio allergens,
three out of five have been characterized as globu-
lins, and one is an albumin storage protein which is
common among other tree nuts. This study, aimed to
investigate in vitro IgE cross-reactivity between the
allergenic proteins of pistachio nut and the homolo-
gous proteins present in almond, cashew, and peanut
by using the sera from a group of patients who had a
history of allergy to pistachio and the other tree nuts.
METHODS
SURVEY METHOD
A structured questionnaire was employed to obtain
demographic information and details about allergic
reactions to pistachio nut and three other tree nuts in-
cluding cashew, almond, and peanut. Sampling was
done randomly. Two different populations were ap-
proached to study the influence of the exposure to
pistachio on the prevalence of allergic reactions to
pistachio and the other nuts. One of the groups re-
sided in Kerman Province, known to be the largest
pistachio cultivation site in the world. The other
group inhabited regions outside this cultivation area.
Volunteers completed the questionnaire themselves
or as guardians for children under the age of 18. In
total 1724 questionnaires from the target populations
were used. Among the 564 responses from the cities
within the cultivation region, 40% were men and 60%
were women. The average age was 31.35 ± 13.6 yr.
For the population outside the pistachio cultivation
regions, there were 1160 responses, of which 33%
were men and 67% women, with an average age of
37 ± 10 yr.
The data were entered into the Access database for
further analysis. In the questionnaires, respondents
described their reactions to nuts by selecting among
a variety of symptoms, including skin (urticaria,
erythema, edema), gastrointestinal tract (vomiting,
diarrhea, abdominal pain), respiratory tract (breath-
ing difficulties, wheezing, throat tightness, coughing,
nasal congestion), and cardiovascular symptoms
(drop in blood pressure, loss of consciousness), as
well as other symptoms (itchy throat and conjunctivi-
tis). The first occurrence of allergic reactions and
probable allergy to other foods andor pollens
were also asked. The percentage of each nut allergy
was calculated on the basis of the total number of re-
spondents.
PISTACHIO PROTEIN EXTRACT
De-fatting of pistachio powder was performed using
cold hexane (115 wv) and shaking for 16 hours.
Hexane was removed by suction and then phosphate-
buffered saline (PBS, pH: 7.4) was added to the sam-
ples (110 wv) and shaken for 8 hours. After a cen-
trifugation at 9000 g for 30 minutes, the supernatant
of the mixture was dialyzed against PBS for 24 hours.
The whole extraction procedure was performed at
4℃. Protein concentration was measured using the
Bradford protein assay, with BSA as the standard pro-
tein.8
PATIENTS AND SKIN PRICK TEST (SPT)
The diagnosis of pistachio allergy was based on clini-
cal history, positive skin prick test (SPT), positive
specific IgE assay (Table 1), and the results of West-
ern blotting. To study the IgE cross-reactivities of pis-
tachio with the other nuts, three of pistachio allergic
patients were selected who had a history of clinical al-
lergic reactions, Western blot results, and specific
IgE reactions to cashew, almond, and peanut protein
extracts, as well (Table 2). Two subjects who showed
negative SPT responses and no specific IgE to pista-
chio extract were considered as negative controls.
SPT with a wheal diameter >3 mm were considered
positive compared with the results obtained with
negative and positive controls. The sera were stored
at -30℃ until use. The study protocol was approved
by the Human Ethics Committee of the Avicenna Re-
search Institute.
The clinical features of the three patients selected
are as follows:
Patient 1
The first case was a nine-year-old boy with a history
of vomiting, cough, gastrointestinal symptoms, and
skin itching after the ingestion of pistachio. He had
developed an anaphylactic reaction following the con-
sumption of cashew and almond, and also suffered
from coughing and immediate lip itching after eating
peanut.
Patient 2
The second case was a 31-year-old man with a history
of oral itching with angioedema of the lips and oral
mucosa immediately after eating pistachio. He also
suffered from coughing and oral itching following in-
gestion of almond and peanut, in addition to oral itch-
ing with angioedema of the lips after cashew con-
sumption.
Patient 3
The third case was a 32-year-old woman with a his-
tory of seasonal rhino-conjunctivitis who had suffered
from an oral allergy syndrome, vomiting, and skin
rash after the ingestion of pistachio. She also had ex-
perienced itchy throat and angioedema of the lips im-
mediately after eating almond and peanut, and oral
itching upon consuming cashew. She stated that she
had consumed cashew only once in her life.
IgE ELISA
Specific ELISA was performed as described previ-
Pistachio Cross-Reactivity
Allergology International Vol 60, No4, 2011 www.jsaweb.jp 427
Table　1　Clinical characteristics, specifi c IgE-reactivity and skin prick test responses of the selected patients with allergy to pis-
tachio nut
Patient No. Age (years)/sex Clinical characteristics †
Pistachio nut extract
Specifi c IgE (OD) ‡ Skin prick test (mm)
1 22/M E, SI 1.1 ND
2 20/M OAS, SI, C 1.2 3
3 21/F OAS, SI 0.99 4
4 36/F SI 0.80 5
5 36/F OAS, SI 0.74 4
6 9/M V, C, G, SI 0.65 3
7 31/M OAS, SI 0.66 5
8 24/M G, V, R 0.56 -
9 50/F SI, G 0.43 ND
10 34/F R, SI 0.61 6
11 40/F SI, C 0.66 5
12 44/M R, SI 0.45 4
13 35/M R, SI 0.57 ND
14 24/F OAS 0.32 ND
15 19/F OAS, SI, C 0.81 6
16 53/F G, V, C 0.3 3
17 50/M G, V 0.3 -
18 20/F SI, OAS 0.80 3
19 24/M OAS, R, SI 0.48 4
20 32/F SI, OAS, V, R 0.81 6
21 25/M E, R, C 0.59 10
† C, Cough; E, Eczema; R, Rhinitis; G, Gastrointestinal symptoms; SI, Skin itching; OAS, Oral allergy syndrome (OAS; defi ned as the on-
set of immediate oral itching with or without angioedema of the lips and oral mucosa); V, Vomiting. ND, Not determined.
‡ OD, Optical density at 450 nm.
Table　2　Specifi c IgE to pistachio, almond, peanut, and ca-
shew of three patients with pistachio nut allergy
Patient No. 1 2 3
Specifi c IgE (OD)
Pistachio 0.65 0.66 0.81
Almond 0.72 0.68 0.74
Peanut 0.87 0.87 0.76
Cashew 0.47 0.76 0.57
OD, Optical density at 450 nm. 
ously9 with minor modifications. Briefly, polystyrene
plates (Nunc Maxisorb, Roskilde, Denmark) were
coated with 0.1 mlwell of a coating buffer (15 mM
Na2CO3 and 35 mM NaHCO3, pH 9.6) containing 10
μgml of different nuts protein at 4℃ for 16 h. The
amount of antigen to be used for plate coating was de-
termined on the basis of preliminary titration experi-
ments. The plates were washed with PBS pH 7.2 con-
taining 0.05% (vv) Tween 20 (PBS-T). Remaining re-
active sites on the solid phase were saturated with
200 μl 2% BSA (overnight at 4℃). After washing, pre-
diluted 1 : 5 human sera were added to the wells and
the plate was incubated overnight at room tempera-
ture. The plate was then washed with PBS-T and then
incubated with biotinylated anti-human IgE (KPL,
Gaithersburg, MD, USA) (1 : 2000 vv in PBS) for
two hours at room temperature. The unbound anti-
bodies were removed from the wells by washing,
which was followed by incubation with HRP-linked
streptavidin (BD Biosciences, MD, USA) (1 : 20000
vv in PBS) for 45 minutes at room temperature. Af-
ter visualization of the enzymatic activity with te-
tramethylbenzidine (TMB) as a substrate at 37℃ for
15 minutes, the reaction was stopped by the addition
of 100 μl of 3N HCl, and absorption was measured at
450 nm. The assays were performed in duplicate.
WESTERN BLOTTING ASSAY AND INHIBITION
WESTERN BLOT
Total extract of pistachio nut from different samples
were subjected to a reducing 12% (wv) SDS-PAGE.10
Separated protein bands by electrophoresis were
electro-transferred to Polyvinylidene difluoride
(PVDF) membranes (Immobilon P, Millipore Corp.,
Bedford, MA, USA).11 After blocking with 2% BSA for
16 hours at 4℃, the blots were incubated for 16 hours
at 4℃ with human sera, diluted 1 : 6 in PBS. The
blots were then incubated with anti-human IgE biotin-
conjugated goat antibody (KPL) (1 : 1000 diluted in
Noorbakhsh R et al.
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Fig.　1　The comparison between percentage of allergy to 
cashew, almond, and peanut among pistachio allergic sub-
jects in pistachio and non pistachio cultivation regions in 
Iran.
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BSA 1%) for 2 hours at room temperature. After each
step, washing was done 3 times with PBS with shak-
ing followed by one hour of incubation with horserad-
ish peroxidase streptavidin (BD Biosciences) (1 :
40000 diluted). Blots were incubated with Supersig-
nal West Pico Chemiluminescent Substrate Kit
(Pierce, USA) for 5 min, and binding antibodies were
then visualized by chemiluminescence using G-Box
gel documentation system (Syngene, Cambridge,
UK). For the inhibition experiment, 150 μl of individ-
ual serum with IgE reactivity to pistachio nut extract
was mixed with 150 μl of total extract of pistachio ex-
tract (containing 70 μg protein) and shaken at room
temperature for three hours. Incubated serum was
used to assess the reactivity on PVDF membrane
blotted with raw extract of different nuts as described
above.
COMPETITIVE INHIBITION ELISA
A pooled serum from the three patients was pre-
pared. Ninety-six-well ELISA microplates (Nunc Max-
isorb, Roskilde, Denmark) were coated with raw pis-
tachio nut extract (10 μgwell in 0.1M sodium bicar-
bonate, pH 9.6) and incubated overnight at 4℃.
Plates were then washed four times with PBS-T and
blocked with 2% BSA for one hour at 37℃. After
washing, 100 μl of pooled sera from the three patients
were pre-incubated for two hours at room tempera-
ture with 0.01, 0.1, 1, 10, 100, and 1000 μg of cashew,
almond, and peanut protein extract as inhibitors or
with BSA as a negative control. Incubated sera were
added to each well and the plates were incubated
overnight at room temperature. Plates were washed
again and then incubated with biotinylated anti-
human IgE (KPL) (1 : 1000 vv in 1% BSA) for two
hours at room temperature. The unbound antibodies
were removed from the wells by washing, which was
then followed by incubation with 1 : 20000 vv in
BSA1% HRP- linked streptavidin (BD Biosciences) for
45 minutes at room temperature. After visualization
of the enzymatic activity with tetramethylbenzidine
(TMB) as a substrate at 37°C for 15 minutes, the re-
action was stopped by the addition of 100 μl of 3N
HCl, and absorption was measured at 450 nm. The as-
says were performed in duplicate.
RESULTS
According to the questionnaires, pistachio allergy
was diagnosed based on the allergy symptoms which
were declared by respondents. The results revealed
that pistachio allergy was prevalent among 0.65% of
the surveyed subjects who lived in cities within the
pistachio cultivation regions and 0.3% for those resid-
ing in regions outside the pistachio cultivation area.
This two-fold difference could prove that being ex-
posed to pistachio may significantly affect the preva-
lence of allergenicity among inhabitants of pistachio
cultivation areas. On the other hand, pistachio aller-
gic patients in pistachio rich area reported more aller-
gic reactions to cashew and almond compared to the
other group which lived in regions outside the culti-
vation area (Fig. 1).
The results of the Western blot for twenty-one indi-
viduals with pistachio allergy (Table 1), which were
confirmed by SPTs and documented histories of aller-
gic reactions, revealed the presence of at least eleven
bands according to their molecular weights (Fig. 2).
The prevalence of the IgE reactivity to each individ-
ual allergen of pistachio among the twenty-one aller-
gic patients is illustrated in Figure 3. Sera from 90.5%
of pistachio allergic patients reacted with a protein
with an apparent molecular weight (MW) of 36 kDa
which may correspond to Pis v5, an 11S globulin
subunit.2,3 Another protein band with an apparent
MW of 32 kDa and that corresponded to an 11S
globulin, was also recognized by the 42.8% of the pa-
tients’ sera. Furthermore, 47.6% of allergic sera de-
tected a protein band with the approximate MW of 55
kDa which could be related to vicillin. Considering
the apparent MW of manganese superoxide dismu-
tase, it could be assumed this allergen was probed by
47.6 percent of allergic patients’ sera. So far, manga-
nese superoxide dismutase has not been detected in
any other nuts.12
To study the possible cross-reactivity between pis-
tachio and three other nuts including cashew, peanut,
and almond, the protein patterns of these nuts were
first analyzed. Figure 4 presents similarities among
apparent molecular weights of pistachio nut protein
bands as well as for the proteins of the other three
nuts. In the second step, inhibition Western blot and
inhibition ELISA were carried out to determine the
IgE reactivity of pistachio allergic patients’ sera to-
wards cashew, almond, and peanut extracts. Inhibi-
tion Western blot, using sera from three pistachio al-
lergic subjects and pre-incubating with crude pista-
Pistachio Cross-Reactivity
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Fig.　2　IgE Immunoblot of pistachio extracts using twenty one allergic patients’ sera. Lane MW, low mo-
lecular weight (Amersham, Buckinghamshire, UK); lanes 1-21, probed with individual patients’ sera; lane 
N, negative control.
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Fig.　3　Prevalence of different IgE-reactive pistachio’s pro-
tein using twenty one pistachio allergic patients’ sera.
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Fig.　4　SDS-PAGE (12%) of protein extracts from different 
nuts. Almond (A); Peanut (Pe); Cashew (C); Pistachio (Pi);
and Low molecular weight marker (Amersham) (MW).
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chio extract showed that IgE binding to cashew pro-
tein blotted strips was significantly abrogated. This
suggests cross-reactivity between these two nuts. For
the almond blotted strips, the majority of IgE binding
proteins were inhibited by pistachio extract except
for an allergen of approximately 20 kDa (Fig. 5). A
limited inhibition with pistachio extract was also
proven when the strips were blotted with peanut.
The results of inhibition ELISA presented the IgE
reactivity of pistachio allergic patients’ sera towards
cashew, almond, and peanut extracts. The pre-
incubation of pooled sera with cashew extract re-
sulted in a significant decrease in IgE reactivity, fol-
lowed by almond extract. Pre-incubation sera with
peanut extract did not show minimal inhibition
(IC50) at the maximum inhibitor concentration of
1000 μgmL, indicating the lack of sufficient cross-
reactive allergens in this extract (Fig. 6).
DISCUSSION
The data from our study’s survey revealed that the
prevalence of pistachio allergy is twice as much in
pistachio cultivation regions than other areas. It has
previously been reported that since allergic people
avoid the consumption of those allergenic foods, al-
lergic reactions mostly occur due to hidden or unde-
clared allergens in products.13 To the best of our
knowledge, pistachio is the most commonly con-
sumed nut in the pistachio cultivation regions in Iran.
It is also predictable that allergic people in these culti-
vation regions are more exposed to pistachio aller-
gens in the course of their lives. Spanjersberg et al.
(2007) suggested a probabilistic model for the rela-
tionship between the exposure to allergenic materials
and the frequency of allergic reactions.13
In this study, based on the Western blot results of
twenty one pistachio allergic subjects, at least eleven
allergens were found to exist in pistachio. The most
frequent allergen (90.5) was 36 KDa protein followed
Noorbakhsh R et al.
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Fig.　5　Western blot result of IgE binding to different immobilized nuts along with their pistachio nut inhibited ex-
tracts, probed using three individual patients’ sera (a, b, and c). Negative control (N); A1 (Almond); A2 (immobilized 
almond inhibited with pistachio); Pe1 (Peanut); Pe2 (immobilized peanut inhibited with pistachio); C1 (Cashew); C2 
(immobilized cashew inhibited with pistachio); Pi (pistachio); Low molecular weight marker (Amersham) (MW).
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Fig.　6　Competitive inhibition ELISA of IgE binding to im-
mobilized raw pistachio nut extract by increasing concentra-
tions of pistachio, cashew, almond, and peanut extracts us-
ing patients’ pooled sera.
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by 62, 55, 22.5, 32, 72, 27, 45, 14, 17, and 42.5 KDa
proteins respectively. Malet et al. (1994) detected five
allergenic fractions in pistachio by the means of SDS-
PAGE immunoblotting; the 57.1 and 74.0 kDa aller-
genic fractions were those that most frequently
bound IgE to the studied sera.14 E. Funes et al.
(1999) demonstrated that the most common aller-
gens were around 14, 30, 40, and 55 kDa.15 It means
there are more pistachio allergens that need to be
identified. In addition, the considerable variability re-
ported in the IgE recognition of pistachio proteins
could be a source of different cross-reactivities be-
tween pistachio and the other nuts in different popu-
lation groups. On the other hand, SDS-PAGE results
of pistachio, cashew, almond, and peanut proteins re-
vealed that the similarity in their apparent molecular
weight may provide clues to the correspondence
among their proteins.
The existence of cross-reactivity among different
nuts has also been extensively investigated.16-22 Data
from the Food Allergy and Anaphylaxis Network’s
Peanut and Tree Nut Registry (FAAN), shows the fol-
lowing percentages of self-reported reactions among
allergic patients: 34% to walnuts, 20% to cashew, 15%
to almond, 9% to pecans, 7% to pistachio, and less than
5% each to hazelnuts, Brazil nuts, pine nuts, macada-
mia nuts, and hickory nuts.16 In studies on children
with tree nut allergies, 92% of 111 patients with pea-
nut allergy, tree nut allergy, or both showed elevated
IgE levels to more than one tree nut, while 37% of 54
patients had experienced convincing reactions and
showed specific IgE levels to more than one nut.19 In
our study, allergy symptoms to cashew, almond, and
peanut were investigated among the pistachio allergic
populations. Considering the fact that, in the main
pistachio cultivation regions of Iran, the inhabitants
traditionally consume pistachio as a part of their
usual diet, the results revealed more reported allergic
reactions to cashew and almond than those in non-
pistachio cultivation regions. The lower number of
peanut’s allergic reactions in the pistachio rich area
might be due to little consumption of this nut or the
limited IgE cross-reactivity between pistachio and
peanut. Several studies suggested that there may be
some common allergens among different tree nuts.
For instance, a study on 142 peanut allergic patients
indicated 50% positive skin tests to almond, 40% to
cashew, 30% to pistachio, 26% to Brazil nuts, and 21%
to hazelnuts.23 It has also been reported that multiple
tree nut sensitivities observed in allergic subjects
may be due to cross-reactive IgE epitopes present in
homologous tree nut allergens.24 The CAP-inhibition
studies revealed a significant cross-reactivity between
Pistachio Cross-Reactivity
Allergology International Vol 60, No4, 2011 www.jsaweb.jp 431
pistachio and cashew nuts both belonging to the
Anacardiaceae family and also between pistachio and
other dried fruits belonging to taxonomically unre-
lated botanical families.25 It was shown that peanut is
serologically IgE cross-reactive with pistachio. It has
also been reported that hazelnuts, cashew, Brazil
nuts, pistachio, and almond make up a group of mod-
erately cross-reactive tree nuts.20 The results of this
study also suggest that the cross-reactivity among the
tree nuts is related to botanical family associations:
pistachio and cashew belong to the same botanical
family, Anacardiaceae, followed by pistachioalmond,
and pistachiopeanut in the same botanical subclass,
Rosaceae. However, this finding is in contrast to a
past study which reported the observed level of cross
reactivity between peanut, almond, Brazil nuts,
cashew and hazelnuts did not correlate with the plant
taxonomic relationship.21 In the present study, the
cross-reactivity between pistachiocashew and pista-
chioalmond were proven by an inhibition ELISA and
also an inhibition Western blot. The inhibition ELISA
did not demonstrate minimal inhibition at the maxi-
mum inhibitor concentration of 1000 μgmL, thus in-
dicating an insufficient cross-reactivity between pista-
chio and peanut. These data suggest that in the pista-
chio rich regions, pistachio are highly consumed by
local inhabitants; hence, the immune system is ex-
posed to several B cell and T cell epitopes from differ-
ent pistachio antigens. These epitopes might be the
cause of the high occurrence of type one food allergy
reactions and consequently, an increased number of
cross-reactive responses to other nuts. The results of
this study’s survey also confirmed that exposure to
pistachio positively affected the incidence of cashew
and almond allergies. In conclusion, although the
overall consumption of cashew, almond, and peanut
is low in the pistachio rich regions of Iran, in compari-
son with pistachio, we deem to point out that cashew,
almond, and, to some extent, peanut, may represent
allergic sensitization in pistachio allergic patients due
to cross-reactivity. More studies with purified aller-
gens or families of allergens are needed to clarify the
allergens, the involved epitopes, and the homology of
the proteins responsible for the cross-reactivity be-
tween pistachio and other nuts.
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